Clinical Trials Logo

Dysfunctional Breathing clinical trials

View clinical trials related to Dysfunctional Breathing.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04734795 Completed - Asthma Clinical Trials

The Prevalence of Dysfunctional Breathing in Children and Adolescents With Asthma

Start date: February 5, 2021
Phase:
Study type: Observational

The purpose of the study is to investigate the prevalence of dysfunctional breathing in children and adolescents with asthma in a hospital outpatient clinic. Participants are invited to take the Nijmegen Questionnaire and the Asthma Control Questionnaire. The prevalence of dysfunctional breathing defined as NQ score >= 23 is calculated, and demographics are compared between children with and without dysfunctional breathing.

NCT ID: NCT04215341 Completed - Clinical trials for Dysfunctional Breathing

Physiotherapy for Children With Dysfunctional Breathing

PhysDB
Start date: August 4, 2014
Phase: N/A
Study type: Interventional

Dysfunctional breathing in children primarily affects the ability to participate in sport or exercise but can also stop children doing other activities such as playing musical instruments. Clinical experience has shown that physiotherapy (through the use of breathing retraining and other associated techniques) can stop the symptoms of dysfunctional breathing, allowing children to return to normal activities and reduce or stop inhaled medications. Whilst there is some evidence in adults with this condition to support the use of physiotherapy, there have been no studies carried out in children investigating whether physiotherapy is beneficial for children with dysfunctional breathing. This study therefore aims to investigate the feasibility of a future large scale multicentre clinical trial designed to investigate whether physiotherapy improves outcomes for children with dysfunctional breathing. The improved management of this common but under recognised condition would lead to significant improvements in the quality of life of children coupled with the reduction in potentially harmful medications.

NCT ID: NCT01575665 Completed - Hyperventilation Clinical Trials

Normalizing CO2 in Chronic Hyperventilation by a Novel Breathing Mask: A Pilot Study

HVMASKE
Start date: February 2011
Phase: N/A
Study type: Interventional

Background: Chronic Idiopathic Hyperventilation (CIH) is a form of dysfunctional breathing which has proven hard to treat effectively. The investigators hypothesised that by periodically inducing normocapnia over several weeks, it would be possible to raise the normal resting level/set point of CO2 and achieve a reduction of symptoms. Methods: Six CIH patients were treated two hours a day for four weeks with a novel breathing mask. The mask was used to induce normocapnia in these chronically hypocapnic patients. Capillary blood gases (PcCO2, pH, Standard Base Excess (SBE) etc.) were measured at baseline and once each week at least three hours after mask use, as well as spirometric values, breath holding tolerance and hyperventilation symptoms as per the Nijmegen Questionnaire (NQ),.